4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-26-001970
Director sold 240 shares at an average $550.33 ($132,080)
- Director acquired 240 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taub Rebecca Director | 2026-01-09 | Option exercise 10b5-1 | +240 | $15.80 | $3,792 | 455,829 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −40 | $545.79 | $21,832 | 455,789 | D |
| Taub Rebecca Director | 2026-01-09 | Sale 10b5-1 | −200 | $551.24 | $110,248 | 455,589 | D |
| Derivatives | |||||||
| Taub Rebecca Director | 2026-01-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −240 | 0 | D | ||
| Open-market sales · 240 sh · avg $550.33 · $132,080 | |||||||
Loading xslF345X05/wk-form4_1768340287.xml…